IQ EQ Fund Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.83M Sell
99,173
-2,574
-3% -$56K 0.18% 126
2026
Q1
$1.77M Buy
101,747
+18,254
+22% +$346K 0.13% 150
2025
Q4
$1.57M Buy
83,493
+25,231
+43% +$423K 0.11% 154
2025
Q3
$847K Buy
58,262
+25,880
+80% +$369K 0.06% 228
2025
Q2
$633K Buy
32,382
+12,900
+66% +$229K 0.06% 248
2025
Q1
$346K Buy
19,482
+10,139
+109% +$218K 0.04% 258
2024
Q4
$200K Buy
9,343
+2,742
+42% +$66.7K 0.02% 272
2024
Q3
$206K Buy
+6,601
New +$164K 0.02% 306

Other funds holding CDNA

IQ EQ Fund Management's CDNA Position: Q2 2026 in Review

IQ EQ Fund Management reduced its CareDx (CDNA) stake by 2.5% in Q2 2026, selling an estimated $56K and leaving 99,173 shares worth $2.83M. The position accounts for 0.18% of the portfolio, ranked #126.

IQ EQ Fund Management first reported a position in CDNA in Q3 2024 and has held it in 8 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • IQ EQ Fund Management held 99,173 shares of CareDx worth $2.83M as of Q2 2026.
  • IQ EQ Fund Management sold 2,574 CareDx shares in Q2 2026, an estimated $56K.
  • CareDx made up 0.18% of IQ EQ Fund Management's portfolio in Q2 2026, its #126 holding.
  • IQ EQ Fund Management first reported a position in CareDx in Q3 2024 and has held it in 8 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.